A Trial to Evaluate the Immunogenicity of Dasiglucagon and GlucaGen in Patients With Type 1 Diabetes Mellitus

NCT03216226 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

112

Enrollment

INDUSTRY

Sponsor class

Conditions

Hypoglycemia
Diabetes Mellitus, Type 1

Interventions

DRUG: dasiglucagon
DRUG: GlucaGen

Sponsor

Zealand Pharma

Collaborators

[object Object]